IDDF2018-ABS-0080 Risk factors for local recurrence in the treatment of radiofrequency ablation with cool-tip electrode for HCC patients. (June 2018)

• Record Type: Journal Article
• Authors: Thu Huyen, Nguyen Thi; Bang, Mai Hong; Riep, Tran Van; Thinh, Nguyen Tien
• Is Part Of: Gut. Volume 67(2018)Supplement 2
• Page Start: A95
• Page End: A95
• Publication Date: 2018-06
• Subjects: Gastroenterology -- Periodicals; 616.33
• DOI: 10.1136/gutjnl-2018-IDDFabstracts.203
• Languages: English
• ISSNs: 0017-5749

Abstract

Abstract : Background: Radiofrequency ablation (RFA) is one of the curative therapies for HCC patients. However, post-RFA local recurrence is a major factor limiting the outcome. The aim of this study was to evaluate the recurrent rate and analyse the risk factors for local recurrence of percutaneous Radiofrequency Ablation using Cool-tip electrode for the treatment of HCC. Methods: A prospective study involved 82 cirrhotic HCC patients (mean tumour size: 3, 2±1, 1 mm) underwent percutaneous RFA using Cool-tip RF electrode (COOL-TIP E SERRIES, COVIDIEN) at the 108 Hospital, from September 2012 to November 2017. We use single gauge, cluster, or multiple electrodes with an exposed needle tip of variable length (2, 3 or 4 cm). The rate of recurrence was recorded, and the prognostic factors for the tumour local recurrence were determined. Results: There were 37/75 of patients presented recurrence after achieved complete response, including local recurrence in 11/75 (14.7%) new nodule recurrence in 16/75 (21.3%) and both local and new nodule recurrence in 7/75 (9.3%). The mean time of recurrence was 23 months (12–45 months). Tumour size (3 cm-5 cm), tumour location (close to vascular), size of ablative margin (<0.5 cm), high serum AFP level had a significant adverse prognostic factor for local tumour recurrence. Conclusions: Although RFA using Cool-tip is an effective treatment for local tumour control in HCC patients, the long term result depends on some prognostic factors before treatment.